Validation of magnetic resonance myocardial perfusion imaging with fractional flow reserve for the detection of significant coronary heart disease

Circulation

Volumn 120, Issue 22, 2009, Pages 2207-2213

  Watkins, Stuart ^a   McGeoch, Ross ^a   Lyne, Jonathan ^b   Steedman, Tracey ^d   Good, Richard ^a   McLaughlin, Mairi Jean ^a   Cunningham, Tony ^d   Bezlyak, Vladimir ^c   Ford, Ian ^c   Dargie, Henry J ^a   Oldroyd, Keith G ^a  

^a GOLDEN JUBILEE NATIONAL HOSPITAL   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d WESTERN INFIRMARY   (United Kingdom)

Author keywords

Angiography; Coronary disease; Fractional flow reserve; Imaging; Magnetic resonance imaging; Myocardial; Perfusion

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GADODIAMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICORANDIL; NITRATE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; FEMALE; FRACTIONAL FLOW RESERVE; HEART MUSCLE PERFUSION; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADENOSINE; AGED; ANGINA PECTORIS; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY DISEASE; FEMALE; GADOLINIUM; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VASODILATOR AGENTS;

EID: 73449103540     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.872358     Document Type: Article

References (38)

1. Eichenberger AC, Schuiki E, Kochli VD, Amann FW, McKinnon GC, Von Schulthess GK. Ischemic heart disease: assessment with gadolinium-enhanced ultrafast MR imaging and dipyridamole stress. J Magn Reson Imaging. 1994;4:425-431.
2. 201thallium-SPECT and coronary angiography. J Magn Reson Imaging. 2000;11:607-615.
3. Ishida N, Sakuma H, Motoyasu M, Okinaka T, Isaka N, Nakano T, Takeda K. Noninfarcted myocardium: correlation between dynamic first-pass contrast-enhanced myocardial MR imaging and quantitative coronary angiography. Radiology. 2003;229:209-216.
4. Schwitter J, Nanz D, Kneifel S, Bertschinger K, Buchi M, Knusel PR, Marincek B, Luscher TF, Von Schulthess GK. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: A comparison with positron emission tomography and coronary angiography. Circulation. 2001;103:2230-2235.
5. Ibrahim T, Nekolla SG, Schreiber K, Odaka K, Volz S, Mehilli J, Guthlin M, Delius W, Schwaiger M. Assessment of coronary flow reserve: comparison between contrast-enhanced magnetic resonance imaging and positron emission tomography. J Am Coll Cardiol. 2002;39:864-870. (Pubitemid 34185336)
6. Al Saadi N, Nagel E, Gross M, Bornstedt A, Schnackenburg B, Klein C, Klimek W, Oswald H, Fleck E. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation. 2000;101:1379-1383.
7. Bertschinger KM, Nanz D, Buechi M, Luescher TF, Marincek B, Von Schulthess GK, Schwitter J. Magnetic resonance myocardial first-pass perfusion imaging: parameter optimization for signal response and cardiac coverage. J Magn Reson Imaging. 2001;14:556-562.
8. Nagel E, Klein C, Paetsch I, Hettwer S, Schnackenburg B, Wegscheider K, Fleck E. Magnetic resonance perfusion measurements for the nonin-vasive detection of coronary artery disease. Circulation. 2003;108: 432-437.
9. Plein S, Greenwood JP, Ridgway JP, Cranny G, Ball SG, Sivananthan MU. Assessment of non-ST-segment elevation acute coronary syndromes with cardiac magnetic resonance imaging. J Am Coll Cardiol. 2004;44: 2173-2181.
10. Paetsch I, Jahnke C, Wahl A, Gebker R, Neuss M, Fleck E, Nagel E. Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation. 2004;110:835-842.
11. Takase B, Nagata M, Kihara T, Kameyawa A, Noya K, Matsui T, Ohsuzu F, Ishihara M, Kurita A. Whole-heart dipyridamole stress first-pass myo-cardial perfusion MRI for the detection of coronary artery disease. Jpn Heart J. 2004;45:475-486.
12. Wolff SD, Schwitter J, Coulden R, Friedrich MG, Bluemke DA, Biederman RW, Martin ET, Lansky AJ, Kashanian F, Foo TKF, Licato PE, Comeau CR. Myocardial first-pass perfusion magnetic resonance imaging: a multicenter dose-ranging study. Circulation. 2004;110: 732-737.
13. Giang TH, Nanz D, Coulden R, Friedrich M, Graves M, Al Saadi N, Luscher TF, Von Schulthess GK, Schwitter J. Detection of coronary artery disease by magnetic resonance myocardial perfusion imaging with various contrast medium doses: first European multi-centre experience. Eur Heart J. 2004;25:1657-1665.
14. Ishida M, Sakuma H, Kato N, Ishida N, Kitagawa K, Shimono T, Yada I, Takeda K. Contrast-enhanced MR imaging for evaluation of coronary artery disease before elective repair of aortic aneurysm. Radiology. 2005; 237:458-464.
15. Plein S, Radjenovic A, Ridgway JP, Barmby D, Greenwood JP, Ball SG, Sivananthan MU. Coronary artery disease: myocardial perfusion MR imaging with sensitivity encoding versus conventional angiography. Radiology. 2005;235:423-430.
16. Ashley EA, Myers J, Froelicher V. Exercise testing in clinical medicine. Lancet. 2000;356:1592-1597.
17. Underwood SR, Anagnostopoulos C, Cerqueira M, Ell PJ, Flint EJ, Harbinson M, Kelion AD, Al Mohammad A, Prvulovich EM, Shaw LJ, Tweddel AC. Myocardial perfusion scintigraphy: the evidence. Eur J Nucl Med Mol Imaging. 2004;31:261-291.
18. Moir S, Haluska BA, Jenkins C, Fathi R, Marwick TH. Incremental benefit of myocardial contrast to combined dipyridamole-exercise stress echocardi-ography for the assessment of coronary artery disease. Circulation. 2004; 110:1108-1113.
19. Sun Z, Lin C, Davidson R, Dong C, Liao Y. Diagnostic value of 64-slice CT angiography in coronary artery disease: a systematic review. Eur J Radiol. 2008;67:78-84.
20. Bech GJ, De Bruyne B, Pijls NH, de Muinck ED, Hoorntje JC, Escaned J, Stella PR, Boersma E, Bartunek J, Koolen JJ, Wijns W. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation. 2001;103:2928-2934.
21. White CW, Wright CB, Doty DB. Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis? New Eng J Med. 1984;310:819-824.
22. Nandalur KR, Dwamena BA, Choudhri AF, Nandalur MR, Carlos RC. Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. J Am Coll Cardiol. 2007;50:1343-1353.
23. De Bruyne B, Baudhuin T, Melin JA, Pijls NHJ, Sys SU, Bol A, Paulus WJ, Heyndrickx GR, Wijns W. Coronary flow reserve calculated from pressure measurements in humans: validation with positron emission tomography. Circulation. 1994;89:1013-1022.
24. Balachandran KP, Berry C, Norrie J, Vallance BD, Malekianpour M, Gilbert TJ, Pell AC, Oldroyd KG. Relation between coronary pressure derived collateral flow, myocardial perfusion grade, and outcome in left ventricular function after rescue percutaneous coronary intervention. Heart. 2004;90:1450-1454.
25. Pijls NHJ, Van Gelder BM, Van der Voort PM, Peels KM, Bracke FALE, Bonnier HJRM, El Gammal MIH. Fractional flow reserve: a useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation. 1995;92:3183-3193.
26. Pijls NHJ, De Bruyne B, Peels K, Van Der Voort PH, Bonner HJRM, Bartunek J, Koolen JJ. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med. 1996; 334:1703-1708.
27. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a Statement for Healthcare Professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105:539-542.
28. Donner A, Klar N. Confidence interval construction for effect measures arising from cluster randomization trials. J Clin Epidemiol. 1993;46: 123-131.
29. Fearon WF, Tonino PA, De Bruyne B, Siebert U, Pijls NH. Rationale and design of the Fractional Flow Reserve Versus Angiography for Mul-tivessel Evaluation (FAME) study. Am Heart J. 2007;154:632-636.
30. Rieber J, Huber A, Erhard I, Mueller S, Schweyer M, Koenig A, Schiele TM, Theisen K, Siebert U, Schoenberg SO, Reiser M, Klauss V. Cardiac magnetic resonance perfusion imaging for the functional assessment of coronary artery disease: a comparison with coronary angiography and fractional flow reserve. Eur Heart J. 2006;27:1465-1471.
31. Costa MA, Shoemaker S, Futamatsu H, Klassen C, Angiolillo DJ, Nguyen M, Siuciak A, Gilmore P, Zenni MM, Guzman L, Bass TA, Wilke N. Quantitative magnetic resonance perfusion imaging detects anatomic and physiologic coronary artery disease as measured by coronary angiography and fractional flow reserve. J Am Coll Cardiol. 2007;50:514-522.
32. Di Bella EV, Parker DL, Sinusas AJ. On the dark rim artifact in dynamic contrast-enhanced MRI myocardial perfusion studies. Magn Reson Med. 2005;54:1295-1299.
33. Pijls NHJ, Klauss V, Siebert U, Powers E, Takazawa K, Fearon WF, Escaned J, Tsurumi Y, Akasaka T, Samady H, De Bruyne B. Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry. Circulation. 2002;105:2950-2954.
34. Leesar MA, Abdul-Baki T, Akkus NI, Sharma A, Kannan T, Bolli R. Use of fractional flow reserve versus stress perfusion scintigraphy after unstable angina: effect on duration of hospitalization, cost, procedural characteristics, and clinical outcome. J Am Coll Cardiol. 2003;41: 1115-1121.
35. De Bruyne B, Pijls NHJ, Bartunek J, Kulecki K, Bech J-W, De Winter H, Van Crombrugge P, Heyndrickx GR, Wijns W. Fractional flow reserve in patients with prior myocardial infarction. Circulation. 2001;104: 157-162.
36. Iskandrian AE, Bateman TM, Belardinelli L, Blackburn B, Cerqueira MD, Hendel RC, Lieu H, Mahmarian JJ, Olmsted A, Underwood SR, Vitola J, Wang W. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol. 2007;14:645-658.
37. Hjortdal VE, Emmertsen K, Stenbog E, Frund T, Schmidt MR, Kromann O, Sorensen K, Pedersen EM. Effects of exercise and respiration on blood flow in total cavopulmonary connection: a real-time magnetic resonance flow study. Circulation. 2003;108:1227-1231.
38. Cheng CP, Herfkens RJ, Taylor CA. Abdominal aortic hemodynamic conditions in healthy subjects aged 50-70 at rest and during lower limb exercise: in vivo quantification using MRI. Atherosclerosis. 2003;168: 323-331.